{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T14:04:53Z","timestamp":1793714693167,"version":"4.6.1"},"reference-count":54,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2019,9,3]],"date-time":"2019-09-03T00:00:00Z","timestamp":1567468800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["31560051"],"award-info":[{"award-number":["31560051"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81560596"],"award-info":[{"award-number":["81560596"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81860644"],"award-info":[{"award-number":["81860644"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2019.02089","type":"journal-article","created":{"date-parts":[[2019,9,3]],"date-time":"2019-09-03T14:58:38Z","timestamp":1567522718000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":42,"title":["Immunogenicity and Safety of the M72\/AS01E Candidate Vaccine Against Tuberculosis: A Meta-Analysis"],"prefix":"10.3389","volume":"10","author":[{"given":"Zhenhua","family":"Ji","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miaomiao","family":"Jian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taigui","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisha","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lianbao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiting","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruolan","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhe","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunfeng","family":"Bi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiyuan","family":"Wen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guozhong","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manzama-Esso","family":"Abi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aihua","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fukai","family":"Bao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2019,9,3]]},"reference":[{"key":"B1","unstructured":"Executive Summary. Global Tuberculosis Report 2018"},{"key":"B2","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1136\/bmj.2.6082.293","article-title":"BCG and vole bacillus vaccines in the prevention of tuberculosis in adolescence and early adult life","volume":"2","author":"Hart","year":"1977","journal-title":"Br Med J"},{"key":"B3","first-page":"276","article-title":"Tuberculosis studies in Muscogee County, Georgia. Twenty-year evaluation of a community trial of BCG vaccination","volume":"91","author":"Comstock","year":"1976","journal-title":"Public Health Rep"},{"key":"B4","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.3389\/fimmu.2017.01134","article-title":"What have we learnt about BCG vaccination in the last 20 years?","volume":"8","author":"Dockrell","year":"2017","journal-title":"Front Immunol"},{"key":"B5","doi-asserted-by":"crossref","first-page":"3998","DOI":"10.1128\/IAI.67.8.3998-4007.1999","article-title":"Cloning, expression, and immunological evaluation of two putative secreted serine protease antigens of Mycobacterium tuberculosis","volume":"67","author":"Skeiky","year":"1999","journal-title":"Infect Immun"},{"key":"B6","doi-asserted-by":"crossref","first-page":"2941","DOI":"10.1128\/IAI.67.6.2941-2950.1999","article-title":"Molecular characterization and human T-cell responses to a member of a novel Mycobacterium tuberculosis mtb39 gene family","volume":"67","author":"Dillon","year":"1999","journal-title":"Infect Immun"},{"key":"B7","doi-asserted-by":"publisher","first-page":"2196","DOI":"10.1016\/j.vaccine.2012.05.035","article-title":"Improved CD4(+) T cell responses to Mycobacterium tuberculosis in PPD-negative adults by M72\/AS01 as compared to the M72\/AS02 and Mtb72F\/AS02 tuberculosis candidate vaccine formulations: a randomized trial","volume":"31","author":"Leroux-Roels","year":"2013","journal-title":"Vaccine"},{"key":"B8","doi-asserted-by":"publisher","first-page":"7618","DOI":"10.4049\/jimmunol.172.12.7618","article-title":"Differential immune responses and protective efficacy induced by components of a tuberculosis polyprotein vaccine, Mtb72F, delivered as naked DNA or recombinant protein","volume":"172","author":"Skeiky","year":"2004","journal-title":"J Immunol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1586\/erv.11.29","article-title":"Recent clinical experience with vaccines using MPL- and QS-21-containing adjuvant systems","volume":"10","author":"Nathalie","year":"2011","journal-title":"Expert Rev Vaccines"},{"key":"B10","doi-asserted-by":"crossref","DOI":"10.1007\/978-1-59259-970-7_12","volume-title":"Monophosphoryl Lipid A and Synthetic Lipid A Mimetics as TLR4-Based Adjuvants and Immunomodulators.","author":"Baldridge","year":"2006"},{"key":"B11","doi-asserted-by":"publisher","first-page":"1360","DOI":"10.1007\/s10875-013-9949-3","article-title":"A randomized, controlled dose-finding phase II study of the M72\/AS01 candidate tuberculosis vaccine in healthy PPD-positive adults","volume":"33","author":"Montoya","year":"2013","journal-title":"J Clin Immunol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"4025","DOI":"10.1016\/j.vaccine.2015.05.088","article-title":"Safety and immunogenicity of candidate vaccine M72\/AS01E in adolescents in a TB endemic setting","volume":"33","author":"Penn-Nicholson","year":"2015","journal-title":"Vaccine"},{"key":"B13","doi-asserted-by":"publisher","first-page":"1769","DOI":"10.1097\/QAD.0000000000000343","article-title":"Safety and immunogenicity of the M72\/AS01 candidate tuberculosis vaccine in HIV-infected adults on combination antiretroviral therapy: a phase I\/II, randomized trial","volume":"28","author":"Thacher","year":"2014","journal-title":"AIDS"},{"key":"B14","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1016\/j.tube.2014.07.001","article-title":"Safety and immunogenicity of the M72\/AS01 candidate tuberculosis vaccine when given as a booster to BCG in Gambian infants: an open-label randomized controlled trial","volume":"94","author":"Idoko","year":"2014","journal-title":"Tuberculosis"},{"key":"B15","doi-asserted-by":"publisher","first-page":"e2459","DOI":"10.1097\/MD.0000000000002459","article-title":"A randomized, controlled safety, and immunogenicity trial of the M72\/AS01 candidate tuberculosis vaccine in HIV-positive Indian adults","volume":"95","author":"Kumarasamy","year":"2016","journal-title":"Medicine"},{"key":"B16","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.tube.2016.07.005","article-title":"Safety and immunogenicity of the M72\/AS01E candidate tuberculosis vaccine in adults with tuberculosis: a phase II randomized study","volume":"100","author":"Gillard","year":"2016","journal-title":"Tuberculosis"},{"key":"B17","doi-asserted-by":"publisher","first-page":"1621","DOI":"10.1056\/NEJMoa1803484","article-title":"Phase 2b controlled trial of M72\/AS01E vaccine to prevent tuberculosis","volume":"379","author":"Van Der Meeren","year":"2018","journal-title":"N Engl J Med"},{"key":"B18","unstructured":"HigginsJPT DeeksJJ The Cochrane CollaborationChapter 7: Selecting studies and collecting data. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.02011"},{"key":"B19","doi-asserted-by":"publisher","first-page":"e1000097","DOI":"10.1371\/journal.pmed.1000097","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"6","author":"Moher","year":"2009","journal-title":"PLoS Med"},{"key":"B20","unstructured":"HigginsJPT AltmanDG SterneJAC The Cochrane CollaborationChapter 8: Assessing risk of bias in included studies. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.02011"},{"key":"B21","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.ijmyco.2015.12.001","article-title":"Populations of latent Mycobacterium tuberculosis lack a cell wall: isolation, visualization, and whole-genome characterization","volume":"5","author":"Velayati","year":"2016","journal-title":"Int J Mycobacteriol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1007\/s12026-011-8229-7","article-title":"Latent tuberculosis: what the host \u201csees\u201d?","volume":"50","author":"Gideon","year":"2011","journal-title":"Immunol Res"},{"key":"B23","doi-asserted-by":"publisher","first-page":"564","DOI":"10.3389\/fimmu.2018.00564","article-title":"Adjuvant-associated peripheral blood mRNA profiles and kinetics induced by the adjuvanted recombinant protein candidate tuberculosis vaccine M72\/AS01 in bacillus Calmette-Guerin-vaccinated adults","volume":"9","author":"Van","year":"2018","journal-title":"Front immunol"},{"key":"B24","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.tube.2006.01.008","article-title":"The role of antibody-mediated immunity in defense against Mycobacterium tuberculosis: advances toward a novel vaccine strategy","volume":"86","author":"Glatman-Freedman","year":"2006","journal-title":"Tuberculosis"},{"key":"B25","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1016\/j.ajpath.2012.05.009","article-title":"Activated B cells in the granulomas of nonhuman primates infected with Mycobacterium tuberculosis","volume":"181","author":"Phuah","year":"2012","journal-title":"Am J Pathol"},{"key":"B26","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1038\/35084083","article-title":"The heparin-binding haemagglutinin of M. tuberculosis is required for extrapulmonary dissemination","volume":"412","author":"Pethe","year":"2001","journal-title":"Nature"},{"key":"B27","doi-asserted-by":"publisher","first-page":"e13120","DOI":"10.1097\/MD.0000000000013120","article-title":"Long-term safety and immunogenicity of the M72\/AS01E candidate tuberculosis vaccine in HIV-positive and -negative Indian adults: results from a phase II randomized controlled trial","volume":"97","author":"Kumarasamy","year":"2018","journal-title":"Medicine"},{"key":"B28","doi-asserted-by":"publisher","first-page":"1863","DOI":"10.1056\/NEJMoa1102287","article-title":"First results of phase 3 trial of RTS, S\/AS01 malaria vaccine in African children","volume":"365","author":"Agnandji","year":"2011","journal-title":"N Engl J Med"},{"key":"B29","doi-asserted-by":"publisher","first-page":"2284","DOI":"10.1056\/NEJMoa1208394","article-title":"A phase 3 trial of RTS, S\/AS01 malaria vaccine in African infants","volume":"367","author":"Agnandji","year":"2012","journal-title":"N Engl J Med"},{"key":"B30","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.3389\/fimmu.2017.01008","article-title":"RTS, S\/AS01E malaria vaccine induces memory and polyfunctional T Cell responses in a pediatric African phase III trial","volume":"8","author":"Moncunill","year":"2017","journal-title":"Front immunol"},{"key":"B31","doi-asserted-by":"publisher","first-page":"3126","DOI":"10.1016\/j.vaccine.2012.01.088","article-title":"Cell-mediated immune responses to a varicella-zoster virus glycoprotein E vaccine using both a TLR agonist and QS21 in mice","volume":"30","author":"Dendouga","year":"2012","journal-title":"Vaccine"},{"key":"B32","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1016\/S0264-410X(94)80052-2","article-title":"Phase 1 trial of immunological adjuvant QS-21 with a GM2 ganglioside-keyhole limpet haemocyanin conjugate vaccine in patients with malignant melanoma","volume":"12","author":"Livingston","year":"1994","journal-title":"Vaccine"},{"key":"B33","doi-asserted-by":"publisher","first-page":"iv24","DOI":"10.1136\/ard.2005.042531","article-title":"Immunological control of tuberculosis: role of tumour necrosis factor and more","volume":"64","author":"Stenger","year":"2005","journal-title":"Ann Rheum Dis"},{"key":"B34","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.tube.2003.08.010","article-title":"Immunology of tuberculosis and implications in vaccine development","volume":"84","author":"Flynn","year":"2004","journal-title":"Tuberculosis"},{"key":"B35","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.cyto.2008.05.002","article-title":"Mycobacterium tuberculosis-specific CD4+, IFNgamma+, and TNFalpha+ multifunctional memory T cells coexpress GM-CSF","volume":"43","author":"Henrik","year":"2008","journal-title":"Cytokine"},{"key":"B36","doi-asserted-by":"publisher","first-page":"2659","DOI":"10.4049\/jimmunol.0900947","article-title":"Quality and vaccine efficacy of CD4+ T cell responses directed to dominant and subdominant epitopes in ESAT-6 from Mycobacterium tuberculosis","volume":"183","author":"Aagaard","year":"2009","journal-title":"J Immunol"},{"key":"B37","doi-asserted-by":"publisher","first-page":"8047","DOI":"10.4049\/jimmunol.0801592","article-title":"Tuberculosis subunit vaccination provides long-term protective immunity characterized by multifunctional CD4 memory T cells","volume":"182","author":"Lindenstr\u00f8m","year":"2009","journal-title":"J Immunol"},{"key":"B38","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1164\/rccm.201003-0334OC","article-title":"Specific T cell frequency and cytokine expression profile do not correlate with protection against tuberculosis after bacillus Calmette-Guerin vaccination of newborns","volume":"182","author":"Kagina","year":"2010","journal-title":"Am J Respir Crit Care Med"},{"key":"B39","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1056\/NEJMoa011110","article-title":"Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent","volume":"345","author":"Keane","year":"2001","journal-title":"N Engl J Med"},{"key":"B40","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1038\/ni1449","article-title":"IL-23 and IL-17 in the establishment of protective pulmonary CD4+ T cell responses after vaccination and during Mycobacterium tuberculosis challenge","volume":"8","author":"Khader","year":"2007","journal-title":"Nat Immunol"},{"key":"B41","doi-asserted-by":"publisher","first-page":"5217","DOI":"10.4049\/jimmunol.178.8.5217","article-title":"Dynamic relationship between IFN-gamma and IL-2 profile of Mycobacterium tuberculosis-specific T cells and antigen load","volume":"178","author":"Millington","year":"2007","journal-title":"J Immunol"},{"key":"B42","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1111\/j.1600-065X.2010.00997.x","article-title":"Views of immunology: effector T cells","volume":"240","author":"Lewinsohn","year":"2011","journal-title":"Immunol Rev."},{"key":"B43","doi-asserted-by":"publisher","first-page":"1809","DOI":"10.1038\/srep01809","article-title":"Prominent role for T cell-derived tumour necrosis factor for sustained control of Mycobacterium tuberculosis infection","volume":"3","author":"Allie","year":"2013","journal-title":"Sci Rep."},{"key":"B44","doi-asserted-by":"publisher","first-page":"854507","DOI":"10.1155\/2015\/854507","article-title":"T1 and T17 cells in tuberculosis: protection, pathology, and biomarkers","volume":"2015","author":"Lyadova","year":"2015","journal-title":"Mediators Inflamm."},{"key":"B45","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1038\/nm1592","article-title":"Multifunctional TH1 cells defne a correlate of vaccine-mediated protection against Leishmania major","volume":"13","author":"Darrah","year":"2007","journal-title":"Nat Med."},{"key":"B46","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1164\/rccm.201208-1385OC","article-title":"Induction and regulation of T-cell immunity by the novel tuberculosis vaccine M72\/AS01 in South African adults","volume":"188","author":"Day","year":"2013","journal-title":"Am J Respir Crit Care Med"},{"key":"B47","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.tube.2012.10.011","article-title":"The candidate tuberculosis vaccine Mtb72F\/AS02 in PPD positive adults: a randomized controlled phase I\/II study","volume":"93","author":"Spertini","year":"2013","journal-title":"Tuberculosis"},{"key":"B48","doi-asserted-by":"publisher","first-page":"e1007643","DOI":"10.1371\/journal.ppat.1007643","article-title":"A comparison of antigen-specific T cell responses induced by six novel tuberculosis vaccine candidates","volume":"15","author":"Rodo","year":"2019","journal-title":"PLoS Pathog"},{"key":"B49","doi-asserted-by":"publisher","first-page":"2222","DOI":"10.4049\/jimmunol.1101122","article-title":"Functional capacity of Mycobacterium tuberculosis-specific T cell responses in humans is associated with mycobacterial load","volume":"187","author":"Day","year":"2011","journal-title":"J immunol"},{"key":"B50","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.intimp.2017.10.026","article-title":"Down-regulation of Notch signaling pathway reverses the Th1\/Th2 imbalance in tuberculosis patients","volume":"54","author":"Li","year":"2018","journal-title":"Int Immunopharmacol"},{"key":"B51","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/14760584.2019.1585246","article-title":"Deciphering protective immunity against tuberculosis: implications for vaccine development","volume":"4","author":"Counoupas","year":"2019","journal-title":"Expert Rve Vaccines"},{"key":"B52","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1016\/S1473-3099(14)70845-X","article-title":"Safety and immunogenicity of a candidate tuberculsis vaccine MVA85A delivered by aerosol in BCG-vaccinated healthy adults: a phase 1, double-blind, randomised controlled trial","volume":"14","author":"Satti","year":"2014","journal-title":"Lancet Infect Dis"},{"key":"B53","doi-asserted-by":"publisher","first-page":"1672","DOI":"10.1056\/NEJMe1812483","article-title":"New Promise for Vaccines against Tuberculosis","volume":"379","author":"Bloom","year":"2018","journal-title":"N Engl J Med"},{"key":"B54","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/S1473-3099(19)30003-9","article-title":"A new tuberculsis vaccine: breakthrough, challenges, and a call for collaboration","volume":"19","author":"Vekemans","year":"2019","journal-title":"Lancet Infect Dis"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2019.02089\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,18]],"date-time":"2021-01-18T01:49:15Z","timestamp":1610934555000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2019.02089\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9,3]]},"references-count":54,"alternative-id":["10.3389\/fimmu.2019.02089"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2019.02089","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,9,3]]},"article-number":"2089"}}